Skip to main content

Animations

MJFF Publications

4481 - 4490 of 9037 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2022
  • 2022
  • 2024
  • 2022
  • 2023
  • 2024
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-022-00520-4
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Activation mechanism of PINK1
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-021-04340-2
    Citation Count: 201
  • Summary Details
    OPEN
    Title: Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2113489119
    Citation Count: 85
  • Summary Details
    OPEN
    Title: A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot Study
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000521232
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Mutation of the ALS-/FTD-Associated RNA-Binding Protein FUS Affects Axonal Development
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa, cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1523/jneurosci.2148-23.2024
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-021-00999-y
    Citation Count: 612
  • Summary Details
    OPEN
    Title: Feed-forward metabotropic signaling by Cav1 Ca2+ channels supports pacemaking in pedunculopontine cholinergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106328
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Improved measurement of disease progression in people living with early Parkinson’s disease using digital health technologies
    Journal Name: Communications Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43856-024-00481-3
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Alzheimer's Disease Sequencing Project release 4 whole genome sequencing dataset
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.70237
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Combinatorial selective ER-phagy remodels the ER during neurogenesis
    Journal Name: Nature Cell Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41556-024-01356-4
    Citation Count: 42
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.